Histamine-2 Receptor Antagonist [EPC]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Histamine-2 Receptor Antagonist [EPC] includes 4 drugs with a combined 427,792 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
427,792
Combined Reports
All Histamine-2 Receptor Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| RANITIDINE | Ranitidine | 418,307 | 26,824 | 7,673 | 6.4% |
| FAMOTIDINE | FAMOTIDINE | 8,347 | 441 | 1,410 | 5.3% |
| CIMETIDINE | Equate Cimetidine | 1,017 | 73 | 389 | 7.2% |
| NIZATIDINE | Nizatidine | 121 | 1 | 19 | 0.8% |
Common Side Effects in Histamine-2 Receptor Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Prostate cancer | 60,641 | 1,031 |
| Breast cancer | 45,671 | 861 |
| Colorectal cancer | 45,528 | 2,584 |
| Bladder cancer | 41,984 | 1,998 |
| Renal cancer | 40,791 | 1,678 |
| Oesophageal carcinoma | 26,229 | 3,806 |
| Gastric cancer | 18,927 | 2,795 |
| Hepatic cancer | 17,818 | 4,081 |
| Pancreatic carcinoma | 15,752 | 4,174 |
| Lung neoplasm malignant | 15,214 | 2,359 |